Skip to main navigation
  • R&D
    • Research
    • Novel Proprietary Systems
    • Science Communications
  • Therapeutic Approach
  • About Us
  • Careers
  • Investors
  • LinkedIn
  • Terms of Service
  • Privacy Policy
  • Careers
Contact

info@metagenomi.co

 

© 2026 Metagenomi Therapeutics, Inc.

HERO

News Releases

Investor Menu

Investor Relations

  • Most Recent Information
  • News & Events
    • News Releases
    • Events
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Analyst Coverage
  • Corporate Governance
    • Documents & Charters
    • Management Team
    • Board of Directors
    • Committee Composition
  • Financials & Filings
    • Annual Reports
    • SEC Filings
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

News Releases

05.28.26
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference

News Releases

05.11.26
Metagenomi Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

News Releases

04.16.26
Metagenomi Therapeutics, Inc. Announces Publication in Nature Structural & Molecular Biology Highlighting Proprietary Compact CRISPR Nuclease with Enhanced Genome Editing Efficiency

News Releases

03.05.26
Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results

News Releases

02.23.26
Metagenomi Therapeutics, Inc. to Present at the 46th Annual TD Cowen Healthcare Conference

News Releases

01.12.26
Metagenomi Announces Corporate Name Change to Metagenomi Therapeutics, Inc. and Highlights Recent Business Milestones and 2026 Corporate Outlook
Headquarters
5959 Horton St, Floor 7
Emeryville, California 94608

Other Locations

1545 Park Avenue
Emeryville, California 94608

1485 Park Avenue
Emeryville, California 94608

Contact

info@metagenomi.co

 
  • LinkedIn
  • Terms of Service
  • Privacy Policy
  • Careers

© 2026 Metagenomi Therapeutics, Inc.

© 2026 Metagenomi Therapeutics, Inc.